Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
There were two LA hackerspaces represented at our 10th anniversary party, and members from both of them were able to give a talk on the projects coming out of their labs. [Arko] from null space labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results